Edition:
United Kingdom

AVROBIO Inc (AVRO.OQ)

AVRO.OQ on NASDAQ Stock Exchange Global Select Market

26.40USD
15 Oct 2018
Change (% chg)

$1.23 (+4.89%)
Prev Close
$25.17
Open
$25.19
Day's High
$26.70
Day's Low
$24.58
Volume
22,961
Avg. Vol
--
52-wk High
$53.70
52-wk Low
$20.30

Latest Key Developments (Source: Significant Developments)

Avrobio Gets No Objection To Clinical Trial Application From Health Canada
Monday, 1 Oct 2018 

Oct 1 (Reuters) - AVROBIO Inc ::AVROBIO RECEIVES NO OBJECTION TO CLINICAL TRIAL APPLICATION FROM HEALTH CANADA FOR AVR-RD-02 GENE THERAPY FOR GAUCHER DISEASE.AVROBIO INC - AVROBIO CONTINUES TO ADVANCE ITS PIPELINE OF GENE THERAPIES FOR LYSOSOMAL STORAGE DISORDERS.AVROBIO INC - COMPANY PLANS TO INITIATE PHASE 1/2 CLINICAL TRIAL IN PATIENTS WITH GAUCHER DISEASE IN 2019.  Full Article

AVROBIO Shares Debut About 54 Pct above IPO Price
Thursday, 21 Jun 2018 

June 21 (Reuters) - :AVROBIO INC SHARES OPEN AT $29.25 IN DEBUT ON THE NASDAQ VERSUS IPO PRICE OF $19.00/SHARE.  Full Article

Avrobio Announces Pricing Of Initial Public Offering
Thursday, 21 Jun 2018 

June 20 (Reuters) - AVROBIO Inc ::AVROBIO, INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING.SAYS INITIAL PUBLIC OFFERING OF 5.25 MILLION COMMON SHARES PRICED AT $19.00PER SHARE.  Full Article